tirzepatide versus semaglutide for weight loss vs Tirzepatide vs. Semaglutide: What's the

Weight Outcomes After 1 year of follow-up with continuous treatment, the mean (SD) weight was 89.9 (22.4) kg in the semaglutide 2.4 mg cohort and 87.6 (22.6) kg in the tirzepatide cohort (Table 3)

For patients without a gallbladder, this gradual approach may be particularly important, allowing time to assess digestive tolerance at each dose level

Research has shown that maintaining optimal testosterone levels is crucial for reducing the risks of conditions like osteoporosis and sarcopenia

Clinical Rationale: Patient-specific justifications highlighting Wegovys unique benefits, such as superior weight reduction and lower adverse effect profiles compared to alternative medications

Taken together, it has been proposed that muscle loss during GLP-1 RAs-based therapy is largely adaptive and proportional to overall weight reduction, and that improvements in muscle quality and insulin sensitivity may help offset potential functional decline [97]